Fabrication and evaluation of pH-dependent polymeric microspheres of ivabradine and their in vitro and in vivo studies
- 55 Downloads
The aim of this work was the development and evaluation of controlled release formulations consisting of methacrylate derivatives and ethyl cellulose synthesized using oil-in-oil solvent evaporation method. Drug release studies were performed in different dissolution media. Maximum drug released was observed at pH 7.4. Fourier transform infrared spectroscopy spectra, SEM and thermal analysis showed compatibility between drug and polymers. Pharmacokinetic parameters were calculated by Phoenix WinNonlin® version 6.3 software. The average AUC0–t was found to be 2483.71 ± 13.173 ng/ml h, 5954.37 ± 12.110 ng/ml h, 6400.82 ± 19.131 ng/ml h and 7427.4 ± 49.322 ng/ml h for group 1–4, respectively. The maximum concentration (Cmax) of IBH for all groups predicted from pharmacokinetics data was 880.38 ng/ml, 718.43 ng/ml, 721.87 ng/ml and 805.11 ng/ml, respectively. Thus, in vitro and in vivo drug release studies of polymeric microspheres proved their controlled release behavior with preferential delivery for an extended period of time.
KeywordsMicrospheres FTIR Pharmacokinetic models HPLC Ivabradine
The authors are very thankful to Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan, for the support of this work.
Compliance with ethical standards
Conflict of interest
Authors have no conflict of interest to declare.
- 4.Mutalik S, Udupa N (2005) Formulation development, in vitro and in vivo evaluation of membrane controlled transdermal systems of glibenclamide. J Pharm Pharm Sci 8:26–38Google Scholar
- 5.Verma S, Kaul M, Rawat A, Saini S (2011) An overview on buccal drug delivery system. IJPSR 2:1303–1321Google Scholar
- 6.Alagusundaram M, Chengaiah B, Ramkanth S, Parameswari SA, Madhu C, Chetty S, Dhachinamoorthi D (2009) Formulation and evaluation of mucoadhesive buccal films of ranitidine. Int J PharmTech Res 1:557–563Google Scholar
- 10.Zhang Y, Sun W, Pan Y, Li T, Yang X, Xu R, Qiu X (2016) Pharmacokinetics changes of ivabradine and N-desmethyl ivabradine after oral administration with puerarin in rats. Int J Clin Exp Med. 9:8369–8374Google Scholar
- 12.Guo Y-J, Liang D-L, Xu Z-S, Ye Q (2014) In vivo inhibitory effects of puerarin on selected rat cytochrome P450 isoenzymes. Die Pharm An IJPS 69:367–370Google Scholar
- 14.Dupinder K, Seema S (2014) Development and characterization of lovastatin loaded microspheres. IJPDT 4:71–78Google Scholar
- 16.Mundargi RC, Srirangarajan S, Agnihotri SA, Patil SA, Ravindra S, Setty SB, Aminabhavi TM (2007) Development and evaluation of novel biodegradable microspheres based on poly (d, l-lactide-co-glycolide) and poly (ε-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies. J Control Release 119:59–68CrossRefGoogle Scholar
- 24.Lu C, Jia Y, Yang J, Jin X, Song Y, Liu W, Ding Y, Sun X, Wen A (2012) Simultaneous determination of ivabradine and N-desmethylivabradine in human plasma and urine using a LC-MS/MS method: application to a pharmacokinetic study. APSB 2:205–212Google Scholar
- 26.Sahoo SK, Mallick AA, Barik B, Senapati PC (2005) Formulation and in vitro evaluation of Eudragit® microspheres of stavudine. Trop J Pharm Res 4:369–375Google Scholar
- 35.Dang T, Cui Y, Chen Y, Meng X, Tang B, Wu J (2015) Preparation and characterization of colon-specific microspheres of diclofenac for colorectal cancer. Trop J Pharm Res 14:1541–1547Google Scholar
- 36.Chella N, Yada KK, Vempati R (2010) Preparation and evaluation of ethyl cellulose microspheres containing diclofenac sodium by novel w/o/o emulsion method. J Pharm Sci Res 2:884–888Google Scholar
- 37.Selva Kumar P, Pandiyan K, Rajagopal K (2014) Development and validation of rapid RP-HPLC method for dissolution release of ivabradine hydrochloride in solid oral dosage form. WJPPS 3:1877–1888Google Scholar
- 40.Khan H, Hanif M (2017) Ivabradine loaded solid lipid microparticles: formulation, characterization and optimization by central composite rotatable design. Acta Pol Pharm 74:211–226Google Scholar
- 43.Ramteke KH, Nath L (2012) Formulation, evaluation and optimization of controlled release hydrogel microspheres for colon targeted drug delivery. J Pharm Sci Res 4:1739–1747Google Scholar